PC

Paul Cyril Coffey

Director Director DIN 07055969
DIN 07055969 First appointment Dec 2014 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2014
Shareholding value Locked Premium profile

About Paul Cyril Coffey

Data last updated:

Paul Cyril Coffey has 11 years in corporate governance. Formerly with 1 company, such as Abbvie Therapeutics India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07055969
Primary Designation Director
First Appointment 30 Dec 2014
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director30 Dec 20141994Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Abbvie Therapeutics India Private Limited
Premium access

Shareholding and investment profile for Paul Cyril Coffey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paul Cyril Coffey

Paul Cyril Coffey has 11 years in corporate governance. Formerly with 1 company, such as Abbvie Therapeutics India Private Limited. Engaged in General Business. Contributes to corporate operations.

Paul Cyril Coffey is associated with 0 companies as a director.

Paul Cyril Coffey has expertise in General Business.

Paul Cyril Coffey has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available